EARLY ONSET ALZHEIMER DISEASE
Clinical trials for EARLY ONSET ALZHEIMER DISEASE explained in plain language.
Never miss a new study
Get alerted when new EARLY ONSET ALZHEIMER DISEASE trials appear
Sign up with your email to follow new studies for EARLY ONSET ALZHEIMER DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Gene therapy tackles Alzheimer's in High-Risk patients
Disease control CompletedThis study tested a gene therapy called LX1001 in 15 people with a specific genetic form of Alzheimer's disease (APOE4 homozygotes). The goal was to check if the treatment is safe and to look for side effects. Participants had mild cognitive impairment or mild to moderate dementi…
Matched conditions: EARLY ONSET ALZHEIMER DISEASE
Phase: PHASE1, PHASE2 • Sponsor: Lexeo Therapeutics • Aim: Disease control
Last updated May 17, 2026 05:49 UTC
-
Blood test breakthrough: a new way to spot Alzheimer's?
Diagnosis CompletedThis study looked at whether a blood test can help diagnose Alzheimer's disease. Researchers measured two specific proteins in the blood of 200 people (some with Alzheimer's, some healthy) to see if the test could tell the difference. The goal is to create a simpler, less invasiv…
Matched conditions: EARLY ONSET ALZHEIMER DISEASE
Sponsor: Amoneta Diagnostics SAS • Aim: Diagnosis
Last updated May 15, 2026 11:53 UTC